跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RETSEVMO 80 mg CAPSULAS DURAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
RETSEVMO 80 mg CAPSULAS DURAS
Approved
STANDARD
RETSEVMO 80 mg CAPSULAS DURAS
Eli Lilly Nederland B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 4, 2021
Approval ID
683a5e09228b83e0
Company
Eli Lilly Nederland B.V.
Type
Standard
Approval Details
Approval Id
683a5e09228b83e0
Drug Cima Aemps Name
RETSEVMO 80 mg CAPSULAS DURAS
Register Number
1201527002
Holder Company Name
Eli Lilly Nederland B.V.
Marketing Company Name
Lilly S.A.
Holder Company Detail Path
/organization/eli-lilly-nederland-bv
Marketing Company Detail Path
/organization/lilly-sa
Authorization Date
2021-03-04
Dosage Form
CÁPSULA DURA
Dose
80 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Eli Lilly Nederland B.V.
Company Detail Path
/organization/eli-lilly-nederland-bv
Company Information
Pharmaceutical Company Name
Eli Lilly Nederland BV
Country Name
Netherlands
Website
http://www.lilly.com/nl
Active Ingredients
SELPERCATINIB
80 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 4, 2021
Approval ID
683a5e09228b83e0
Type
Standard
Back to CIMA-AEMPS Approvals